Vito Lorusso

2.4k total citations · 1 hit paper
60 papers, 1.9k citations indexed

About

Vito Lorusso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vito Lorusso has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vito Lorusso's work include Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Vito Lorusso is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Vito Lorusso collaborates with scholars based in Italy, United States and Germany. Vito Lorusso's co-authors include Luigi Cavanna, Friedrich Cavagna, Bruce G. Jenkins, Fabio Maggioni, Massimo Daprà, Piero Tirone, Sandro Barni, Giovanni Scambia, Roberto Labianca and Erminio Bonizzoni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Vito Lorusso

60 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

2009 446 citations Luigi Cavanna, Sandro Barni et al. profile →

Peers

Vito Lorusso

ONCOL

RNMI

CCM

Robert T. OʼDonnell United States

Christopher Poole United Kingdom

Michael A. Savin United States

Olivier Couturier France

Albert Abad Spain

Scott N. Holden United States

Jamey Skillings Canada

Jean Marc Extra France

Renuka Iyer United States

Fabio A.B. Schutz United States

Robert T. OʼDonnell United States

Vito Lorusso

645 ×1.2

ONCOL

1.1k ×2.6

RNMI

151 ×0.4

63 ×0.2

108 ×0.4

CCM

Citations per year, relative to Vito Lorusso Vito Lorusso (= 1×) peers Robert T. OʼDonnell

Countries citing papers authored by Vito Lorusso

Since Specialization

Citations

This map shows the geographic impact of Vito Lorusso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Lorusso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Lorusso more than expected).

Fields of papers citing papers by Vito Lorusso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Lorusso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Lorusso. The network helps show where Vito Lorusso may publish in the future.

Co-authorship network of co-authors of Vito Lorusso

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Lorusso. A scholar is included among the top collaborators of Vito Lorusso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Lorusso. Vito Lorusso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Passardi, Alessandro, Oriana Nanni, Davide Tassinari, et al.. (2015). Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial. Annals of Oncology. 26(6). 1201–1207. 121 indexed citations

Gridelli, Cesare, Filippo de Marinis, Andrea Ardizzoni, et al.. (2014). Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study. Journal of Cancer Research and Clinical Oncology. 140(10). 1783–1793. 9 indexed citations

Marinis, Filippo de, Andrea Ardizzoni, Gabriella Fontanini, et al.. (2014). Management of Italian Patients With Advanced Non–Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study. Clinical Lung Cancer. 15(5). 338–345.e1. 7 indexed citations

Lorusso, Vito. (2011). Which role for EGFR therapy in breast cancer?. Frontiers in Bioscience-Scholar. S4(1). 31–31. 4 indexed citations

Gridelli, Cesare, Andrea Ardizzoni, Sandro Barni, et al.. (2011). Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational “SUN” (Survey on the lUng cancer maNagement) study. Lung Cancer. 74(3). 462–468. 13 indexed citations

Calvani, Nicola, Franco Morelli, Silvana Leo, et al.. (2011). Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter?. Medical Oncology. 29(3). 1908–1913. 12 indexed citations

Vergara, Daniele, Andrea Tinelli, Carlo Siciliano, et al.. (2011). Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Letters. 310(1). 1–8. 81 indexed citations

Delfino, Riccarda, Matteo Altissimo, R.H. Menk, et al.. (2011). X‐ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd‐based magnetic resonance imaging contrast agent. Clinical and Experimental Pharmacology and Physiology. 38(12). 834–845. 12 indexed citations

Laurentiis, Michelino De, Daniela Cianniello, R. Caputo, et al.. (2010). Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treatment Reviews. 36. S80–S86. 146 indexed citations

10.

Metro, Giulio, Diana Giannarelli, Gaetano Lanzetta, et al.. (2009). Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast Cancer. The Breast Journal. 16(1). 66–72. 10 indexed citations

11.

Gebbia, Vittorio, Vito Lorusso, Domenico Galetta, et al.. (2009). First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Lung Cancer. 69(2). 218–224. 15 indexed citations

12.

Lorusso, Vito, et al.. (2009). Single dose of palonosetron plus dexamethasone to control nausea, vomiting and to warrant an adequate food intake in patients treated with highly emetogenic chemotherapy (HEC). Preliminary results. Supportive Care in Cancer. 17(12). 1469–1473. 15 indexed citations

13.

Cornily, Jean‐Christophe, Fabien Hyafil, Claudia Calcagno, et al.. (2008). Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin‐binding intravascular contrast agent and MRI. Journal of Magnetic Resonance Imaging. 27(6). 1406–1411. 25 indexed citations

14.

Adamo, Vincenzo, Vito Lorusso, Rosalba Rossello, et al.. (2008). Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. British Journal of Cancer. 98(12). 1916–1921. 20 indexed citations

15.

Setti, Ilaria, et al.. (2006). High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent Gadocoletate ion in human plasma, urine and faeces. Journal of Chromatography B. 835(1-2). 1–15. 1 indexed citations

16.

Lorusso, Vito, Lorella Pascolo, Cristina Fernetti, et al.. (2005). Magnetic Resonance Contrast Agents: From the Bench to the Patient. Current Pharmaceutical Design. 11(31). 4079–4098. 30 indexed citations

17.

Pascolo, Lorella, Siniša Petrović, Felicia Cupelli, et al.. (2001). ABC Protein Transport of MRI Contrast Agents in Canalicular Rat Liver Plasma Vesicles and Yeast Vacuoles. Biochemical and Biophysical Research Communications. 282(1). 60–66. 52 indexed citations

18.

Spinazzi, Alberto, et al.. (2000). Safety and Pharmacokinetics of a New Liposomal Liver-Specific Contrast Agent for CT. Investigative Radiology. 35(1). 1–1. 19 indexed citations

19.

Spinazzi, Alberto, Vito Lorusso, Gianpaolo Pirovano, et al.. (1998). MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver. Academic Radiology. 5. S86–S89. 65 indexed citations

20.

Haën, Christoph de, Vito Lorusso, & Piero Tirone. (1996). Hepatic transport of gadobenate dimeglumine in TR− rats. Academic Radiology. 3. S452–S454. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact